Trulicity and Wixela inhub drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trulicity (dulaglutide) and Wixela inhub (fluticasone propionate; salmeterol xinafoate). Common drug interactions include cellulitis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Trulicity and Wixela inhub. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Trulicity?

Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.

What is Wixela inhub?

Wixela inhub has active ingredients of fluticasone propionate; salmeterol xinafoate. eHealthMe is studying from 2,925 Wixela inhub users. Check the latest studies of Wixela inhub.

On Jul, 19, 2026

35 people who take Trulicity and Wixela inhub together, and have interactions are studied.

Trulicity and Wixela inhub drug interactions.

What are the common drug interactions of Trulicity and Wixela Inhub, by gender? *:

female:

Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Infusion site haemorrhage (bleeding from infusion site)
Nephrolithiasis (calculi in the kidneys)
Urinary tract infection
Sinusitis (inflammation of sinus)
Seasonal allergy (allergic condition due to certain season)
Asthma
Drug ineffective

male:

Diarrhoea
Asthenia (weakness)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Depressive symptom
Dyspnoea (difficult or laboured respiration)
Ill-defined disorder
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Pancreatic carcinoma (pancreatic cancer)

What are the common drug interactions of Trulicity and Wixela Inhub, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cellulitis (infection under the skin)
Pain

40-49:

n/a

50-59:

Asthma
Oral herpes (viral infection of mouth)

60+:

Hypersensitivity
Immunosuppression
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Infusion site haemorrhage (bleeding from infusion site)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Nasal discharge discolouration (change in colour of nasal discharge)
Nephrolithiasis (calculi in the kidneys)
Oropharyngeal pain
Pancreatic carcinoma (pancreatic cancer)
Psoriasis (immune-mediated disease that affects the skin)

What are the existing conditions these people have? *

Asthma: 8 people, 22.86%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 17.14%
Immunodeficiency Common Variable: 6 people, 17.14%
Immunodeficiency: 6 people, 17.14%
Hereditary Angioedema (recurrent episodes of severe swelling): 4 people, 11.43%
Diabetes: 2 people, 5.71%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 5.71%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Trulicity and Wixela inhub?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously